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THE need to standardize the procedure for implanting tumours when quanti-
tative work is being done is specially important in experiments involving the use
of the titration method, by means of which the tumour-producing potency of a
suspension oftumour cells is estimated (Schrek, 1935; Shear, 1936; Warner and
Gostling, 1950). In work in which the growth rate of tumours is being studied
it is also an advantage, at least theoretically, to base the information gained on
the knowledge that the implantation was done by a uniform method. This is
particularly so when tumours are implanted into pure strain animals in which
their growth tends to be more uniform than in mixed strain animals.
To this end, use has been made of the Agla micrometer syringe (Burroughs
Wellcome) which is designed to deliver accurately uniform volumes. With the
help of a device to facilitate aseptic manipulation of the tumour cell suspensions,
a technique has been developed which makes it possible to implant tumours
rapidly and accurately without the need ofassistance.
The procedure used for routine implanting at one dilution will be described.
A mince is prepared usingCraigie's pressure mincer (Craigie, 1949). There is some
evidence (Epstein, M. A., personal communication) that the best results are
obtained when two plungers of grooves of depths 0.5 and 0.125 mm. are used.
Pieces oftumour for mincing are taken from the peripheral parts oflarge but not
ulcerated tumours. The operation is done aseptically and samples of the mince
are plated on to blood agar before and after the implantation. A volume ofmince
measured as accurately as possible from a syringe, is transferred to a sterile rubber
capped graduated centrifuge tube and sterile 0.9 per cent (w/v) NaCl is added to
make a 50 per cent (v/v) suspension, using the graduations of the tube. The
suspension is then centrifuged at 1000 r.p.m. for 2 minutes to remove minute air
bubbles which remain in the suspension even after the addition of the diluent.
The micrometer syringe is mounted horizontally and rigidly on a stand. The
mounting can be swivelled through 90°, the movement being controlled by a stop
and a tightening screw. The all glass syringe supplied with the instrument has
not been used. It is rather fragile for use in this context and the nozzle has so
fine a bore that blocking by fibrous material in the suspension proved to be
troublesome. Furthermore, the high degree of accuracy of which it is capable
seemed inappropriate for this kind of work. An ordinary good quality Luer
tuberculin syringe has been calibrated and has been shown to be well suited for
attachment to the micrometer fitting. It was found to be more satisfactory toJ. G. BE1NETTE
fill this with the rather viscous suspension by driving this in rather than sucking
it up by withdrawing the plunger in the usual way. The device used to transfer
the mince suspension to the implanting syringe is shown in Fig. 1. A 3-way tap
(1 mm. bore), fitted with the Luer ground joints on two ofthe side arms has been
mounted rigidly between two clear Perspex plates. An all glass Luer 5 ml.
syringe, referred to as the mixing syringe, fits into the socket joint above and is
held firmly by the barrel. A 4 inch Luer exploring needle projects downwards
from the cone joint below and passes through the rubber cap to the bottom ofthe
tube containing the cell suspension. This tube is jacketed by a Dewar flask con-
tainingice and water. To thethird arm ofthetap isattacheda Luerfittingadaptor
which is heldfirmly against the end ofthe side arm by a short piece ofrubber tube
which allows just enough flexibility to eliminate the risk of snapping off the glass
tip of the micrometer syringe when this is inserted into the adaptor for filling.
This part of the apparatus is mounted in such a way that the side arm adaptor
can be adjusted to come into alignment with the micrometer syringe when this
is rotated on its mounting. To fill the implanting syringe at the outset, it is'
necessary to take special care to exclude air bubbles. Thereafter the problem
does not arise. The photograph shows the micrometer syringe in the filling
position. The procedure for filling is as follows: the cell suspension in the
reservoiris thoroughly mixedbydrawing it into and discharging it from the mixing
syringe several times. A small quantity is then drawn up and the tap turned so
that the suspension slowly escapes from the side arm adaptor. Three drops,
approximately the volume ofthe dead space in the tap and adaptor, are discarded.
A meniscus is left just bulging from the end ofthe adaptor. The-tip ofthe micro-
meter syringe is firmly inserted into this and the tap is turned so that the contents
ofthe mixingsyringe can berapidlymixedagainwith the contents ofthe reservoir.
On drawing up another sample, this is directly transferred to the micrometer
syringe which is then detached and returned to its former position ready for im-
planting. A sterile tube is used to protect the side arm adaptorfrom contamination
between filling operations. The suspension left in the mixing syringe is returned
to the cooled reservoir. As the contents ofthis are used up, airis replaced through
a bent hypodermic needle which is stuck through the rubber cap (not shown in
Fig. 1). Number 14 needles have been found to be convenient for implanting.
A sterile one is used after each refilling; when it has been filled with the contents
ofthe implanting syrminge, a little over 0.5 ml. remains, enough to implant 10 mice
with single inoculations.
The sterilizationand assemblyofthe device aresimple and with a little practice
the frequent refilling ofthe implanting syringe does not constitute a disadvantage
from the technical point ofview. The errors due to sedimentation are minimized,
but not, of course, eliminated by this apparatus. The frequent mixing necessary
ensures that the suspension is oxygenated, and this may be an important improve-
ment on the use of a closed syringe as a reservoir, from which the micrometer
syringe was filled in earlier experiments. In some ofthese it was noticed that the
number ofsuccessful implants fell off somewhat towards the end of an implanting
session lasting 2 to 3 hours, and although it cannot be asserted definitely that the
use of the improved procedure was directly responsible for removing this source
of variation, no such difference in take-rate was found after it had been applied.
The whole operation involved in the implantation of 160 mice can be done com-
fortably within 2 hours, single handed. After a little practice it was found to be
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no more difficult to put mice on to a fixed needle than to put the needle into the
mice. The section of optical bench on which the stands are mounted is about
14 inches long, so that there is ample clearance between the two pieces for the
manipulation ofthe injections, when the implanting syringe is put into an oblique
position and the two stands are placed at each end of the optical bench. To get
the necessary rigidity, the base plate is clamped to the edge of a bench during
use.
Since the apparatus has proved to be convenient and reliable in practice it
will be used for future work and further attention will be directed to the problem
of obtaining and handling homogeneous cell suspensions.
SUMMARY.
A device is described which has been designed to facilitate the rapid implan-
tation ofup to 200 mice with an accurately uniform dose ofhomogeneous tumour
cell suspensions under aseptic conditions and without the need of assistance.
Thanks are due to Mr. R. L. Warren for his help in making the apparatus.
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